Carl Zeiss Meditec AG

Total Valuation

Carl Zeiss Meditec AG carries a market capitalization of 2.30B, placing it among publicly traded companies globally. Its enterprise value stands at 3.79B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Carl Zeiss Meditec AG currently has 87.54M shares outstanding.

Valuation Ratios

Carl Zeiss Meditec AG trades at a trailing price-to-earnings ratio of 26.03. The price-to-sales ratio is 1.65, and the price-to-book ratio stands at 2.21.

Enterprise Valuation

On an enterprise value basis, Carl Zeiss Meditec AG trades at an EV/EBITDA multiple of 16.98 and an EV/FCF ratio of 16.53. The EV/Sales ratio of 1.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.98 provides insight into valuation relative to core operating earnings.

Financial Position

Carl Zeiss Meditec AG maintains a current ratio of 2.34, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.23, indicating elevated leverage, while an interest coverage ratio of 8.38 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Carl Zeiss Meditec AG posts a return on equity of 8.72 and a return on invested capital of 7.24.

Taxes

Over the trailing twelve months, Carl Zeiss Meditec AG has paid 51.51M in income taxes, reflecting an effective tax rate of 26.56.

Stock Price Statistics

Carl Zeiss Meditec AG's stock has declined approximately -51.94139% over the past 52 weeks. The 50-day moving average sits at 26.01, while the 200-day moving average is 34.92.

Income Statement

Over the trailing twelve months, Carl Zeiss Meditec AG generated 2.23B in revenue and converted that into 141.22M in net income, yielding earnings per share of 1.63. EBITDA reached 223.36M, while operating income came in at 223.36M.

Balance Sheet

Carl Zeiss Meditec AG holds 27.27M in cash and equivalents against 132.46M in total debt, resulting in a net debt position of -27.27M. Total book value stands at 1.66B, with working capital of 728.14M providing operational flexibility.

Cash Flow

Carl Zeiss Meditec AG produced 209.86M in operating cash flow over the past twelve months.

Margins

Carl Zeiss Meditec AG operates with a gross margin of 52.76, reflecting its pricing power and cost economics. The operating margin of 10.03 and net profit margin of 6.34 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Carl Zeiss Meditec AG's most recent stock split took place on October 24, 2006 with a 1000:1369 split ratio.

Scores

Carl Zeiss Meditec AG posts an Altman Z-Score of 5.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.